Cargando…

Development and Validation of a DNA Methylation-related Classifier of Circulating Tumour Cells to Predict Prognosis and to provide a therapeutic strategy in Lung Adenocarcinoma

Background: A significant factor influencing the prognosis of lung adenocarcinoma (LUAD) is tumor metastasis. Studies have shown that abnormal DNA methylation in circulating tumor cells (CTCs) is associated with tumour metastasis. Based on the genes expressed in CTCs that play an important role in D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Xuyu, Huang, Xianting, Zhang, Xiuxiu, Wang, Cailian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379404/ https://www.ncbi.nlm.nih.gov/pubmed/35982906 http://dx.doi.org/10.7150/ijbs.75284

Ejemplares similares

Development and Validation of an E2F-Related Gene Signature to Predict Prognosis of Patients With Lung Squamous Cell Carcinoma
por: Wang, Cailian, et al.
Publicado: (2021)

High Expression of TACC3 Is Associated with the Poor Prognosis and Immune Infiltration in Lung Adenocarcinoma Patients
por: Chen, Yan, et al.
Publicado: (2022)

Development and validation of a novel fibroblast scoring model for lung adenocarcinoma
por: Wei, Shiyou, et al.
Publicado: (2022)

Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA
por: Wu, Huanwen, et al.
Publicado: (2022)

IRGS: an immune-related gene classifier for lung adenocarcinoma prognosis
por: Shi, Xiaoshun, et al.
Publicado: (2020)

A Comprehensive Bioinformatic Analysis for Identification of Myeloid-Associated Differentiation Marker as a Potential Negative Prognostic Biomarker in Non-Small-Cell Lung Cancer
por: Zhou, Min, et al.
Publicado: (2022)

DNA methylation‐based profiling of bone and soft tissue tumours: a validation study of the ‘DKFZ Sarcoma Classifier’
por: Lyskjær, Iben, et al.
Publicado: (2021)

DNA methylation-based classifier differentiates intrahepatic pancreato-biliary tumours
por: Dragomir, Mihnea P., et al.
Publicado: (2023)

Identification and validation of a muscle failure index to predict prognosis and immunotherapy in lung adenocarcinoma through integrated analysis of bulk and single-cell RNA sequencing data
por: Gu, Xuyu, et al.
Publicado: (2023)

Novel Circulating Tumour Cell-Related Risk Model Indicates Prognosis and Immune Infiltration in Lung Adenocarcinoma
por: Liang, Lu, et al.
Publicado: (2022)

Tumour-stroma ratio and prognosis in gastric adenocarcinoma
por: Kemi, Niko, et al.
Publicado: (2018)

Clinical Applications of Circulating Tumour DNA in Pancreatic Adenocarcinoma
por: Loft, Matthew, et al.
Publicado: (2019)

Development and validation of a robust necroptosis related classifier for colon adenocarcinoma
por: Yang, Jie, et al.
Publicado: (2022)

Comprehensive Explorations of CCL28 in Lung Adenocarcinoma Immunotherapy and Experimental Validation
por: Su, Xiangyu, et al.
Publicado: (2023)

Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Lung Adenocarcinoma
por: Huang, Hua, et al.
Publicado: (2022)

Methods of classifying and ascertaining children's tumours.
por: Leck, I., et al.
Publicado: (1976)

Early detection and prognosis prediction for colorectal cancer by circulating tumour DNA methylation haplotypes: A multicentre cohort study
por: Mo, Shaobo, et al.
Publicado: (2022)

Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma
por: Lohneis, Philipp, et al.
Publicado: (2018)

Validation of a DNA methylation HPV triage classifier in a screening sample
por: Lorincz, Attila T., et al.
Publicado: (2016)

DNA Methylation in Circulating Tumour DNA as a Biomarker for Cancer
por: Board, Ruth E, et al.
Publicado: (2008)

Brain tumour diagnostics using a DNA methylation‐based classifier as a diagnostic support tool
por: Priesterbach‐Ackley, L. P., et al.
Publicado: (2020)

Immune‐related eight‐lncRNA signature for improving prognosis prediction of lung adenocarcinoma
por: Chen, Yan, et al.
Publicado: (2021)

Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design
por: Kejík, Zdeněk, et al.
Publicado: (2021)

Hemicolectomy Does Not Provide Survival Benefit for Right-Sided Mucinous Colon Adenocarcinoma
por: Huang, Jia, et al.
Publicado: (2021)

Predicting lung adenocarcinoma disease progression using methylation-correlated blocks and ensemble machine learning classifiers
por: Yu, Xin, et al.
Publicado: (2021)

Macrophages and monocytes mediated activation of oxidative phosphorylation implicated the prognosis and clinical therapeutic strategy of Wilms tumour
por: Meng, Jialin, et al.
Publicado: (2022)

The measurement and therapeutic implications of circulating tumour cells in breast cancer
por: Smerage, J B, et al.
Publicado: (2006)

A Study of hTERT Promoter Methylation in Circulating Tumour DNAs of Patients with Ovarian Magnificent Tumour
por: Li, Songyi, et al.
Publicado: (2020)

Direct comparison study of DNA methylation markers in EpCAM-positive circulating tumour cells, corresponding circulating tumour DNA, and paired primary tumours in breast cancer
por: Chimonidou, Maria, et al.
Publicado: (2017)

DNA methylation molecular subtypes for prognosis prediction in lung adenocarcinoma
por: Xu, Duoduo, et al.
Publicado: (2022)

Six MicroRNA Prognostic Models for Overall Survival of Lung Adenocarcinoma
por: Li, Juan, et al.
Publicado: (2022)

Circulating tumour cells in patients with lung cancer universally indicate poor prognosis
por: Jin, Fukang, et al.
Publicado: (2022)

Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma
por: Openshaw, Mark R., et al.
Publicado: (2020)

Circulating tumour cell combined with DNA methylation for early detection of hepatocellular carcinoma
por: Liang, Wenjin, et al.
Publicado: (2022)

Method validation of circulating tumour cell enumeration at low cell counts
por: Cummings, Jeffrey, et al.
Publicado: (2013)

A robust CD8(+) T cell-related classifier for predicting the prognosis and efficacy of immunotherapy in stage III lung adenocarcinoma
por: Feng, Jinteng, et al.
Publicado: (2022)

Clinical Significance of a Circulating Tumor Cell-based Classifier in Stage IB Lung Adenocarcinoma: A Multicenter, Cohort Study
por: Ren, Lijuan, et al.
Publicado: (2023)

Methylated circulating tumor DNA in blood: power in cancer prognosis and response
por: Warton, Kristina, et al.
Publicado: (2016)

MINDEC-An Enhanced Negative Depletion Strategy for Circulating Tumour Cell Enrichment
por: Lapin, Morten, et al.
Publicado: (2016)

Methylation of the claudin-3 promoter predicts the prognosis of advanced gastric adenocarcinoma
por: Zhang, Zhenzhen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5ntvo6qmvf35cfo588b7kg4lgr